Elevance Health (ELV) valuation history
Historically high
As of
ELV's EV/EBITDA of 12.9x is higher than 98% of its available weekly readings from the last five years.
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 8.1× | 13% | |
| 7.6× | 6% | |
| 9.5× | 26% | |
| 11.5× | 46% | |
| 12.9× | 83% | |
| 9.7× | 49% | |
| 11.8× | 75% | |
| 11.5× | 79% | |
| 10.7× | 98% | |
| 6.7× | 70% |
Loading related research…
About this history
- What is ELV's current EV/EBITDA?
- ELV's EV/EBITDA of 12.9x is higher than 98% of its available weekly readings from the last five years.
- What is ELV's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 10.5× over the last five years. Available history contains 860 weekly observations from May 3, 2010 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.